Created for it
Developed with your patient's quality of life in mind
Content relating to Edwards Lifesciences devices is intended for healthcare professionals.
Designed to handle the pressure of the mitral position
Edwards Lifesciences has developed the MITRIS RESILIA mitral valve to help meet the specialized needs of your patients.
When replacement is the best choice, what if you had an option designed to be similar to the native valve?
Looks like it
A saddle-shaped sewing cuff mimics the native mitral annulus
Performs like it
Handles the pressure of the mitral position
Key features of the MITRIS valve
Built on the Carpentier-Edwards PERIMOUNT valve platform
a platform with over 20 years of published clinical durability.1
Cobalt chromium bands provide good visibility under fluoroscopy
for easy identification of the landing zone for potential future transcatheter interventions.
Dry storage
to eliminate need for rinsing.
Lowest profile stents
do not obstruct blood flow through the left ventricular outflow tract (LVOT).
^On a label size 25 mm. Anterior Profile Height.
An enhanced delivery experience
Need more information?
RESILIA tissue clinical data:
Backed by a strong and growing body of clinical evidence supporting RESILIA tissue’s ongoing study of durability and hemodynamic performance 2, 3, 4
COMMENCE mitral clinical trial
Clinically stable hemodynamics and one incident of structural valve deterioration (SVD) through 4 years in 82 patients.
Stable gradients Mean gradient (mmHg)
COMMENCE aortic clinical trial
Clinically stable hemodynamics and zero SVD through 5 years in 689 patients*.
*1 SVD diagnosed at post-operative day 1848
Stable gradients Mean gradient (mmHg)
European Aortic Feasibility trial
Clinically stable hemodynamics and zero SVD through 5 years in 133 patients.
Mean gradient (mmHg) Valve sizes 19-27 mm
Promising data. Inspiring results.
MITRIS RESILIA mitral valve surgical technique video
Device preparation animation
MITRIS RESILIA mitral valve
The MITRIS RESILIA valve is designed to handle the pressure of the mitral position.
Built on the trusted Carpentier-Edwards PERIMOUNT valve platform, and made with RESILIA tissue for decreased calcification†, this is the mitral valve developed with your patient's quality of life in mind.
† No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.
Important Safety Information:
For Indications, contraindications and general warnings related to use of MITRIS RESILIA Mitral Valve, please refer to the detailed Instructions for Use.
Key materials list
- Valve leaflets: Bovine pericardium
- Stent: Cobalt-chromium alloy and polyester band with a nitinol wireform
- Fabric stent covering: Polyester and Polytetrafluoroethylene (PTFE) cloth
- Valve sewing ring: Silicone rubber
Tissue platform
The MITRIS valve features RESILIA tissue and is treated with a special integrity preservation technology that effectively eliminates free aldehydes while protecting and preserving tissue.
No clinical data are available that evaluate the long term impact of RESILIA tissue in patients.
General product information
- Storage temperature: 10°C to 25°C
- Storage: Dry storage
- Rinse procedure: None required